U of A spinoff, U.S. firm merge to commercialize transplant technology
Bridge to Life commits US$10 million to clinical trial and commercial development of Tevosol Ex-Vivo Organ Support System
Bridge to Life commits US$10 million to clinical trial and commercial development of Tevosol Ex-Vivo Organ Support System
Platform allows specialists to offer physiotherapy expertise for patients in smaller communities
New industry-led accelerator will address the earliest barriers faced by researchers just starting on the path to commercialization
Local startup founded by U of A graduates teaches basics of programming in more than 30 Edmonton-area schools